EARNINGS BEATS & MISSES · NOV 2, 2026 Regeneron Pharmaceuticals beat EPS estim… · @LenardReads · TwKit

@LenardReads

EARNINGS BEATS & MISSES · NOV 2, 2026 Regeneron Pharmaceuticals beat EPS estimates by +33.9%; Banco Santander Chile missed by -20.0% Of 35 companies above $2.0B that reported on 10/30, 29 beat consensus EPS. Below are the biggest beats, largest first, then the biggest misses, largest first; percentages are actual EPS vs. estimate. 1. REGN Regeneron Pharmaceuticals +33.9% 2. BCH Banco De Chile +28.8% 3. SNY Sanofi +25.1% Follow @LenardReads for daily rankings.

曝光 142 · 评论 3 · 点赞 3 · 书签 0